000 | 01991 a2200517 4500 | ||
---|---|---|---|
005 | 20250513085912.0 | ||
264 | 0 | _c19960522 | |
008 | 199605s 0 0 eng d | ||
022 | _a0010-7824 | ||
024 | 7 |
_a10.1016/0010-7824(95)00191-c _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEndrikat, J | |
245 | 0 | 0 |
_aA twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance. _h[electronic resource] |
260 |
_bContraception _cOct 1995 |
||
300 |
_a229-35 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmenorrhea _xepidemiology |
650 | 0 | 4 |
_aAustria _xepidemiology |
650 | 0 | 4 |
_aBody Weight _xphysiology |
650 | 0 | 4 |
_aContraceptives, Oral _xadverse effects |
650 | 0 | 4 |
_aDesogestrel _xadverse effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aDysmenorrhea _xepidemiology |
650 | 0 | 4 |
_aEthinyl Estradiol _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFrance _xepidemiology |
650 | 0 | 4 |
_aHeadache _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 |
_aMenstrual Cycle _xdrug effects |
650 | 0 | 4 |
_aNausea _xepidemiology |
650 | 0 | 4 |
_aNorpregnenes _xadverse effects |
650 | 0 | 4 |
_aProgesterone Congeners _xadverse effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJaques, M A | |
700 | 1 | _aMayerhofer, M | |
700 | 1 | _aPelissier, C | |
700 | 1 | _aMüller, U | |
700 | 1 | _aDüsterberg, B | |
773 | 0 |
_tContraception _gvol. 52 _gno. 4 _gp. 229-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0010-7824(95)00191-c _zAvailable from publisher's website |
999 |
_c8604829 _d8604829 |